![]() |
市场调查报告书
商品编码
1933295
全球血液透析机市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测(2026-2034)Hemodialysis Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球血液透析机市场规模达到154.4亿美元,预计从2026年的164.8亿美元成长至2034年的312.3亿美元,在预测期(2026-2034年)内年复合成长率(CAGR)为8.32%。北美地区凭藉其先进的医疗基础设施和慢性肾臟病(CKD)的高发病率,在2025年占据全球市场38.11%的占有率。
血液透析是肾衰竭患者维持生命的血液净化过程。它使用透析器(也称为人工肾臟)来清除血液中的毒素和多余液体。治疗可在中心进行,也可居家进行,由于居家治疗的灵活性和生活品质的提高,越来越多的患者选择居家治疗。
市场概览
全球末期肾病(ESRD)病例的增加是推动血液透析机需求的主要因素。糖尿病、高血压、肥胖、遗传性疾病和过量饮酒等因素都会显着增加肾衰竭的风险。根据美国疾病管制与预防中心(CDC)的资料,糖尿病仍然是已开发经济体中 ESRD 的主要原因。
由于住院病患急性肾损伤病例的增加,COVID-19 疫情暂时加速了对透析机的需求。儘管供应链中断和劳动力短缺限制了市场成长,但市场在2021年至2023年期间趋于稳定,并在2024年恢復到疫情前的成长水准。这有望支撑市场在2034年之前的长期扩张。
市场驱动因素
慢性肾臟病(CKD)盛行率上升
全球CKD和末期肾病(ESRD)盛行率的上升是市场成长的主要驱动因素。根据Fresenius Medical Care的资料,2022年全球约有480万人患有肾衰竭,预计到2033年这一数字将超过650万人。光是2022年,全球就有约390万名患者接受透析治疗,将显着增加对透析机、透析器和透析液的需求。
透析设备的技术进步
製造商正加大研发投入,以推出更安全、更紧凑、技术更先进的血液透析系统。诸如改进的液体管理技术、穿戴式肾臟和感染预防配件等创新技术,加速其在医院和家庭医疗保健机构的普及应用。
市场限制因子
儘管需求强劲,但高昂的治疗费用仍然是一大挑战。每年的透析费用从 1万美元到 9万美元不等,其中中心血液透析的平均费用为每位患者每年 7.2万美元到 8.8万美元。此外,人们对某些透析设备可能造成的感染风险和有害化合物暴露的担忧,导致监管审查力度加大,这可能会限制其在对成本敏感地区的普及。
市场趋势
居家血液透析普及率不断提高
影响市场的关键趋势之一是向家庭透析解决方案的转变。由于减少了诊所就诊次数、提高了灵活性并改善了治疗效果,患者越来越倾向于选择居家透析。 Max@Home 和 NephroPlus(2021)等合作项目以及主要製造商推出的先进家庭透析系统加速这一趋势,尤其是在已开发国家。
细分市场分析
依产品划分
市场依产品分为血液透析机和血液透析耗材。
预计到2026年,耗材细分市场将占据主导地位,市场占有率达到 84.51%,这主要得益于对透析器、透析液和血管通路产品的持续需求。由于政府大力推广居家透析,预计透析设备市场将稳定成长。
依最终使用者划分
由于透析手术量大且拥有专业的医疗基础设施,预计到2026年,透析中心和医院将占据最大市场占有率(83.57%)。由于便携式和用户友善系统的日益普及,预计居家医疗保健市场将以显着的年复合成长率成长。
区域洞察
到2025年,北美市场规模达到 58.9亿美元,这主要得益于终末期肾病(ESRD)患病率的上升以及家用透析设备的快速普及。
欧洲则位居第二,这得益于相对宽鬆的监管审批流程和健全的医疗保健体系,其中德国和英国的成长尤为显着。
预计到2034年,亚太地区将实现最高的年复合成长率,这主要得益于中国、日本和印度透析基础设施的扩张。
由于透析中心就诊患者数量的增加,预计拉丁美洲以及中东和非洲地区将保持稳定成长。
The global hemodialysis equipment market was valued at USD 15.44 billion in 2025 and is projected to grow from USD 16.48 billion in 2026 to USD 31.23 billion by 2034, registering a CAGR of 8.32% during the forecast period (2026-2034). North America dominated the global market in 2025 with a 38.11% share, supported by advanced healthcare infrastructure and a high prevalence of chronic kidney disease (CKD).
Hemodialysis is a life-sustaining blood purification process used for patients with kidney failure, in which a dialyzer, often referred to as an artificial kidney, removes toxins and excess fluids from the blood. Treatment is delivered either through in-center hemodialysis or home-based hemodialysis, with growing patient preference for home-based modalities due to flexibility and improved quality of life.
MARKET OVERVIEW
The increasing global burden of end-stage renal disease (ESRD) is a major factor driving the demand for hemodialysis equipment. Conditions such as diabetes, hypertension, obesity, genetic disorders, and excessive alcohol consumption significantly contribute to kidney failure. According to CDC data, diabetes remains the leading cause of ESRD in developed economies.
The COVID-19 pandemic temporarily accelerated demand for dialysis equipment due to acute kidney failure cases among hospitalized patients. Although supply-chain disruptions and workforce shortages constrained growth, the market stabilized during 2021-2023 and is expected to return to pre-pandemic growth levels by 2024, supporting long-term expansion through 2034.
MARKET DRIVERS
Rising Prevalence of Chronic Kidney Disease
The growing prevalence of CKD and ESRD worldwide is the primary driver of market growth. According to Fresenius Medical Care, around 4.8 million people suffered from kidney failure in 2022, a figure projected to exceed 6.5 million by 2033. In 2022 alone, approximately 3.9 million patients globally underwent dialysis treatment, significantly increasing demand for machines, dialyzers, and dialysate.
Technological Advancements in Dialysis Equipment
Manufacturers are increasingly investing in R&D to introduce safer, compact, and technologically advanced hemodialysis systems. Innovations such as improved fluid management, wearable kidneys, and infection-prevention accessories are accelerating adoption across hospitals and home-care settings.
MARKET RESTRAINTS
Despite strong demand, high treatment costs remain a major challenge. Annual dialysis costs range from USD 10,000 to USD 90,000, with in-center hemodialysis averaging USD 72,000-88,000 per patient per year. Additionally, concerns related to infection risks and exposure to toxic compounds from certain dialysis machines have prompted regulatory scrutiny, potentially limiting adoption in cost-sensitive regions.
MARKET TRENDS
Growing Adoption of Home-Based Hemodialysis
A key trend shaping the market is the shift toward home-based dialysis solutions. Patients increasingly prefer home dialysis due to reduced hospital visits, flexibility, and improved outcomes. Partnerships such as Max@Home and NephroPlus (2021) and the launch of advanced home systems by leading manufacturers are accelerating this trend, particularly in developed economies.
SEGMENTATION ANALYSIS
By Product
The market is segmented into hemodialysis machines and hemodialysis consumables.
The consumables segment dominated the market in 2026 with an 84.51% share, driven by the recurring demand for dialyzers, dialysate, and vascular access products. The machines segment is expected to witness steady growth due to government initiatives promoting home dialysis adoption.
By End User
Dialysis centers & hospitals held the largest share in 2026 (83.57%), owing to the high volume of dialysis procedures and the presence of specialized infrastructure. The home healthcare segment is projected to grow at a significant CAGR due to increasing availability of portable and user-friendly systems.
REGIONAL INSIGHTS
North America generated USD 5.89 billion in 2025, driven by rising ESRD prevalence and rapid adoption of home-based machines.
Europe ranked second, supported by favorable regulatory approvals and strong healthcare systems, with Germany and the UK showing notable growth.
Asia Pacific is expected to register the highest CAGR through 2034, fueled by expanding dialysis infrastructure in China, Japan, and India.
Latin America and the Middle East & Africa are witnessing steady growth due to increasing patient visits to dialysis centers.
COMPETITIVE LANDSCAPE
The market is dominated by Fresenius Medical Care and Baxter, supported by extensive product portfolios and strong distribution networks. Other key players include B. Braun SE, NIPRO Corporation, Nikkiso Co., Ltd., Asahi Kasei Medical, Medtronic, and JMS Co., Ltd. Strategic partnerships, FDA approvals, and new product launches continue to strengthen competitive positioning.
CONCLUSION
The global hemodialysis equipment market is poised for robust growth, driven by the rising prevalence of chronic kidney disease, technological advancements, and increasing adoption of home-based dialysis solutions. With the market expanding from USD 15.44 billion in 2025 to USD 31.23 billion by 2034, sustained investments in innovation, supportive government initiatives, and expanding dialysis infrastructure are expected to enhance patient access and treatment outcomes. Despite challenges related to high costs and safety concerns, the long-term outlook remains positive, positioning hemodialysis equipment as a critical component of global renal care management.
Segmentation By Product
By End-user
By Region